Monday, May 03, 2021 1:38:17 AM
Recent BRTX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 10:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:11:57 PM
- BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2025 09:05:00 PM
- BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 • GlobeNewswire Inc. • 11/05/2025 09:30:00 PM
- BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market • GlobeNewswire Inc. • 10/27/2025 11:30:00 AM
- BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio • GlobeNewswire Inc. • 10/22/2025 01:35:00 PM
- BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit • GlobeNewswire Inc. • 10/15/2025 01:35:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/09/2025 04:50:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2025 09:10:43 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/08/2025 08:25:27 PM
- BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show” • GlobeNewswire Inc. • 10/07/2025 01:25:00 PM
- BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market • GlobeNewswire Inc. • 10/06/2025 06:28:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/06/2025 03:55:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2025 03:49:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 09:08:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2025 08:30:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2025 08:16:41 PM
- BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/12/2025 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2025 09:10:29 PM
- BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025 • GlobeNewswire Inc. • 08/05/2025 08:30:00 PM
- BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates • GlobeNewswire Inc. • 06/18/2025 01:35:00 PM
- BioRestorative Announces Share Repurchase Program • GlobeNewswire Inc. • 06/17/2025 01:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 12:31:05 PM
- BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 06/13/2025 11:45:00 AM
ECGI Appoints AI Platform Architect as CTO to Build Mortgage Tokenization Infrastructure • ECGI • Nov 13, 2025 8:30 AM
Alliance Creative Group (ACGX) Releases 2025 Q3 Quarterly Financial and Disclosure Report • ACGX • Nov 13, 2025 4:40 AM
The Hidden Force Behind the AI Revolution • META • Nov 12, 2025 9:00 AM
The Clean Energy Breakthrough That Could Power the AI Era • MAXXF • Nov 12, 2025 9:00 AM
ECGI Highlights Fintech Expansion Through RezyFi Acquisition and Tokenized Mortgage Platform in Shareholder Letter • ECGI • Nov 11, 2025 8:30 AM
The New Gold Rush of the AI Era • ESAU • Nov 10, 2025 9:00 AM
